[Clinical manifestations and treatment of Terson's syndrome].
OBJECTIVE
To present clinical manifestations of Terson's syndrome and the results of treatment of vitreous hemorrhages with the use of intravitreous injections of anti-Rh serum.


METHODS
8 patients with disc, retinal, vitreous hemorrhages and abducens paralysis which developed after subarachnoid hemorrhages. Intravitreous hemorrhages were observed in 4 of those patients.


RESULTS
Vitreous hemorrhages cleared spontaneously in two patients. In the remaining two ones with no tendency for blood resorption intravitreous injections of anti-Rh serum were performed. Vitreous hemorrhage cleared in all the patients after 5-6 weeks and visual acuity improved to 0.8.


CONCLUSIONS
Intravitreous injections of anti-Rh serum can be the method of choice in the treatment of vitreous hemorrhages in Terson's syndrome with no tendency for spontaneous resorption and without proliferative vitreoretinopathy.
Prost
M E
ME
Kliniki Okulistyki Instytutu Pomnika-Centrum Zdrowia Dziecka w Warszawie.
D000293:Adolescent; D000328:Adult; D002648:Child; D006801:Humans; D007167:Immunotherapy; D007518:Isoantibodies / Q000097:blood; D008875:Middle Aged; D012204:Rh-Hr Blood-Group System / Q000276:immunology*; D013345:Subarachnoid Hemorrhage / Q000150:complications* / Q000628:therapy*; D013577:Syndrome; D014823:Vitreous Hemorrhage / Q000209:etiology* / Q000628:therapy*
D007518:Isoantibodies; D012204:Rh-Hr Blood-Group System